Citius Oncology, Stock Price on August 12, 2024
| CTOR Stock | 0.85 0.13 13.27% |
If you're considering investing in Citius Stock, it is important to understand the factors that can impact its price. As of today, the current price of Citius Oncology, stands at 0.85, as last reported on the 24th of November, with the highest price reaching 1.01 and the lowest price hitting 0.85 during the day. Citius Oncology, secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18% return per unit of risk over the last 3 months. Citius Oncology, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Citius Oncology,'s Mean Deviation of 4.87, risk adjusted performance of (0.11), and Standard Deviation of 6.43 to double-check the risk estimate we provide.
At this time, Citius Oncology,'s Total Stockholder Equity is relatively stable compared to the past year. As of 11/24/2024, Stock Based Compensation is likely to grow to about 2.4 M, while Common Stock Shares Outstanding is likely to drop slightly above 57 M. . Citius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Citius |
Sharpe Ratio = -0.1797
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CTOR |
Estimated Market Risk
| 6.35 actual daily | 56 56% of assets are less volatile |
Expected Return
| -1.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Citius Oncology, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Citius Oncology, by adding Citius Oncology, to a well-diversified portfolio.
Price Book 4.5515 | Enterprise Value 116.2 M | Shares Outstanding 2 M | Shares Short Prior Month 10.6 K | Market Capitalization 116.2 M |
Citius Oncology, Main Headline on 12th of August 2024
Insider Trading by MacroaxisInsider Filed transaction by CTOR Director: . Insider Public Trading |
Citius Oncology, Valuation on August 12, 2024
It is possible to determine the worth of Citius Oncology, on a given historical date. On August 12, 2024 Citius was worth 40.5 at the beginning of the trading date compared to the closed value of 40.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Citius Oncology, stock. Still, in general, we apply an absolute valuation method to find Citius Oncology,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Citius Oncology, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Citius Oncology,'s related companies.
| Open | High | Low | Close | Volume | |
08/12/2024 | 40.50 | 40.50 | 40.50 | 40.50 | 1.00 |
| 3.35 | 4.42 | 2.65 | 3.20 | 2,389,100 |
| Backtest Citius Oncology, | | | Citius Oncology, History | | | Citius Oncology, Valuation | Next |
Citius Oncology, Trading Date Momentum on August 12, 2024
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Citius Oncology, Fundamentals Correlations and Trends
By evaluating Citius Oncology,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Citius Oncology,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Citius financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Citius Oncology, Stock history
Citius Oncology, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Citius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Citius Oncology, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Citius Oncology, stock prices may prove useful in developing a viable investing in Citius Oncology,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.1 M | 57 M |
Citius Oncology, Stock Technical Analysis
Citius Oncology, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Citius Oncology, Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Citius Oncology, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Citius Oncology, November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Citius Oncology, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Citius Oncology, shares will generate the highest return on investment. By undertsting and applying Citius Oncology, stock market strength indicators, traders can identify Citius Oncology, entry and exit signals to maximize returns
Citius Oncology, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Citius Oncology,'s price direction in advance. Along with the technical and fundamental analysis of Citius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Citius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (1.98) | |||
| Treynor Ratio | (0.45) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Citius Stock Analysis
When running Citius Oncology,'s price analysis, check to measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.